Steven Cohen’s Pliant Therapeutics PLRX Stock Holding History

Steven Cohen’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.9K	Sell	20,073 -26,981	-57%	-$32.8K	﹤0.01%	3866
2026 Q1	$59.3K	Buy	47,054 +517	+1%	+$653	﹤0.01%	3650
2025 Q4	$56.8K	Sell	46,537 -4,291,857	-99%	-$6.45M	﹤0.01%	3783
2025 Q3	$6.42M	Buy	+4,338,394	New	+$6.62M	0.01%	971
2023 Q2	–	Sell	-9,697	Closed	-$258K	–	2648
2023 Q1	$258K	Buy	+9,697	New	+$276K	﹤0.01%	1403
2022 Q3	–	Sell	-484,524	Closed	-$3.88M	–	1667
2022 Q2	$3.88M	Sell	484,524 -285,476	-37%	-$1.83M	0.02%	774
2022 Q1	$5.4M	Sell	770,000 -365,100	-32%	-$3.73M	0.02%	686
2021 Q4	$15.3M	Buy	+1,135,100	New	+$18M	0.06%	399
2020 Q4	–	Sell	-51,500	Closed	-$1.17M	–	1083
2020 Q3	$1.17M	Buy	+51,500	New	+$1.29M	0.01%	761

Other funds holding PLRX

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Steven Cohen's PLRX Position: Q2 2026 in Review

Steven Cohen reduced its Pliant Therapeutics (PLRX) stake by 57% in Q2 2026, selling an estimated $32.8K and leaving 20,073 shares worth $22.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3866.

Steven Cohen first reported a position in PLRX in Q3 2020 and has held it in 9 quarters since. The position peaked at $15.3M in Q4 2021. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

Steven Cohen held 20,073 shares of Pliant Therapeutics worth $22.9K as of Q2 2026.
Steven Cohen sold 26,981 Pliant Therapeutics shares in Q2 2026, an estimated $32.8K.
Pliant Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #3866 holding.
Steven Cohen first reported a position in Pliant Therapeutics in Q3 2020 and has held it in 9 quarters since.
Steven Cohen's Pliant Therapeutics position peaked at $15.3M in Q4 2021.
86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.